(1) Ferguson JJ, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol. 2001;38:1456-1462. (2) Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-1296. (3) Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomized, open-label trial. Lancet. 2013;382:1638-1645.(4) Kapur NK, Paruchuri V, Majithia A, et al. Hemodynamic effects of standard versus larger-capacity intra-aortic balloon counterpulsation pumps. J Invasive Cardiol. 2015;27:182-188. (5) FDA Executive Summary. https://www.federalregister.gov/documents/2013/12/30/2013-31... [https://www.federalregister.gov/documents/2013/12/30/2013-31...].
Imagen - http://mma.prnewswire.com/media/322743/Getinge___Logo.jpg [http://mma.prnewswire.com/media/322743/Getinge___Logo.jpg]
CONTACTO: CONTACTO: Helena Swan, directora sénior de ComunicacionesInternas y Relaciones Públicas, (973)709-7967, helena.swan@getinge.com
